Insider · CIK 0002114540
Abhimanyu Verma
Files at SOPH (SOPHiA GENETICS SA). First filing Apr 8, 2026, latest Oct 7, 2026.
In brief
Abhimanyu Verma files SEC Form 4 as officer at SOPH (SOPHiA GENETICS SA). Since Apr 8, 2026, Abhimanyu Verma has reported 0 open-market buys worth $0 and 7 open-market sells worth $283k, the latest filed on Oct 7, 2026.
A track record needs three past buys with six months of prices behind them; Abhimanyu Verma has 0, so none is measured yet.
The newest scored trade: sold $43k of SOPH on Oct 5, 2026, filed Oct 7, 2026, scored 16 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 7 sells worth $283k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SOPH: SOPHiA GENETICS SA
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 16Weak | SOPHiA GENETICS SA | $43k 5,284 shares | -3% | +111% from low-8% from high | |
| 19Weak | SOPHiA GENETICS SA | $85k 10,000 shares | -5% | +165% from low0% from high | |
| 16Weak | SOPHiA GENETICS SA | $38k 5,000 shares | -3% | +156% from low0% from high | |
| 16Weak | SOPHiA GENETICS SA | $35k 5,000 shares | -3% | +127% from low0% from high | |
| 15Weak | SOPHiA GENETICS SA | $27k 5,285 shares | -3% | +77% from low-11% from high | |
| 16Weak | SOPHiA GENETICS SA | $38k 6,944 shares | -3% | +90% from low0% from high | |
| 10Weak | SOPHiA GENETICS SA | $17k 3,549 shares | -2% | +86% from low-10% from high |
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 5, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,284 | $8.12 | $43k | 166,887 | 8 d ago |
| Aug 19, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $8.20 | $41k | 177,171 | Aug 26, 2026 |
| Aug 24, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $8.80 | $44k | 172,171 | Aug 26, 2026 |
| Aug 7, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $7.60 | $38k | 182,171 | Aug 10, 2026 |
| Aug 4, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,000 | $6.95 | $35k | 187,171 | Aug 5, 2026 |
| Jul 6, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -5,285 | $5.10 | $27k | 192,171 | Jul 7, 2026 |
| Jun 25, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -6,944 | $5.51 | $38k | 197,456 | Jun 26, 2026 |
| Apr 6, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -2,519 | $4.86 | $12k | 205,430 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Ordinary Shares | +82,136 | $0.00 | $0 | 207,949 | Apr 8, 2026 |
| Apr 7, 2026 | SOPH SOPHiA GENETICS SA | SOpen-market sale Ordinary Shares10b5-1 | -1,030 | $4.87 | $5,016 | 204,400 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Share Option (Right to Buy)derivative | +119,760 | $0.00 | $0 | 119,760 | Apr 8, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Ordinary Shares | +82,136 | $0.00 | $0 | 82,136 | Apr 3, 2026 |
| Apr 2, 2026 | SOPH SOPHiA GENETICS SA | AGrant or award Share Option (Right to Buy)derivative | +119,760 | $0.00 | $0 | 119,760 | Apr 3, 2026 |
Questions about Abhimanyu Verma
Answered from the filings on this page, as of the latest one.
Is Abhimanyu Verma buying or selling?
In the last 12 months Abhimanyu Verma reported 0 open-market buys worth $0 and 7 open-market sells worth $283k on SEC Form 4; the latest was sold $43k of SOPH on Oct 5, 2026. Grants, option exercises and tax withholding are not counted.
How did Abhimanyu Verma's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Abhimanyu Verma has 0.
Where does Abhimanyu Verma file Form 4?
Abhimanyu Verma has filed Form 4 at SOPH (SOPHiA GENETICS SA) as Chief Technology Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.